Apollo Hospitals Enterprise announced that Vinayak Chatterjee (DIN: 00008933), completed his second term as an Independent Director of Apollo Hospitals Enterprise as of 31 March 2024 and consequently ceased to be an Independent Director and a Member of the Board of Directors of the Company effective from the closing hours of 31 March 2024. Powered by Capital Market - Live News

Net profit of Apollo Hospitals Enterprise rose 59.80% to Rs 245.30 crore in the quarter ended December 2023 as against Rs 153.50 crore during the previous quarter ended December 2022. Sales rose 13.77% to Rs 4850.60 crore in the quarter ended December 2023 as against Rs 4263.60 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales4850.604263.60 14 OPM %12.6511.35 - PBDT530.30419.30 26 PBT363.30265.90 37 NP245.30153.50 60 Powered by Capital Market - Live News

Apollo Hospitals Enterprise announced that the Board of Directors of the Company at its meeting held on 8 February 2024, inter alia, have recommended the interim dividend of Rs 6 per equity Share (i.e. 120%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Apollo Hospitals Enterprise will hold a meeting of the Board of Directors of the Company on 8 February 2024.Powered by Capital Market - Live News

Net profit of Apollo Hospitals Enterprise rose 14.17% to Rs 232.90 crore in the quarter ended September 2023 as against Rs 204.00 crore during the previous quarter ended September 2022. Sales rose 14.02% to Rs 4846.90 crore in the quarter ended September 2023 as against Rs 4251.10 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales4846.904251.10 14 OPM %12.9512.99 - PBDT540.50482.10 12 PBT377.10327.10 15 NP232.90204.00 14 Powered by Capital Market - Live News